Bitter melon (Momordica charantia): a natural healthy vegetable

References

• Namsa, N. D.; Mandal, M.; Tangjang, S.; Mandal, S. C. Ethnobotany of the Monpa Ethnic Group at Arunachal Pradesh, India. Journal of Ethnobiology and Ethnomedicine 2011, 7, 31–37. DOI:10.1186/1746-4269-7-31.
   PubMed Web of Science ®Google Scholar
• Puri, R.; Sud, R.; Khaliq, A.; Kumar, M.; Jain, S. Gastrointestinal Toxicity Due to Bitter Bottle Gourd (Lagenaria Siceraria)–A Report of 15 Cases. Indian Journal of Gastroenterology 2011, 30(5), 233–236. DOI: 10.1007/s12664-011-0110-z.
   PubMedGoogle Scholar
• Sabourian, R.; Karimpour-Razkenari, E.; Saeedi, M.; Bagheri, M. S.; Khanavi, M.; Sadati, N.; Akbarzadeh, T.; Ardekani, M. R. Medicinal Plants Used in Iranian Traditional Medicine (ITM) as Contraceptive Agents. Current Trends Biotechnology Pharmacy 2016, 17(11), 974–985. DOI: 10.2174/1389201017666160808162331.
   Google Scholar
• Pandit, S.; Kanjilal, S.; Awasthi, A.; Chaudhary, A.; Banerjee, D.; Bhatt, B. N.; Narwaria, A.; Singh, R.; Dutta, K.; Jaggi, M.; et al., Evaluation of Herb-Drug Interaction of a Polyherbal Ayurvedic Formulation through High Throughput Cytochrome P450 Enzyme Inhibition Assay. Journal of Ethnobiology and Ethnopharmacology 2016, 16, 304–308.
   Google Scholar
• Aziz, M.; Karboune, S. Natural Antimicrobial/Antioxidant Agents in Meat and Poultry Products as Well as Fruits and Vegetables. Critical Reviews in Food Science and Nutrition 2016. DOI:10.1080/10408398.2016.1194256.
   PubMed Web of Science ®Google Scholar
• Tambor, M.; Pavlova, M.; Golinowska, S.; Arsenijevic, J.; Groot, W. Financial Incentives for a Healthy Life Style and Disease Prevention among Older People: A Systematic Literature Review. BMC Health Services Research 2016, 16(5), 426. DOI: 10.1186/s12913-016-1517-0.
   PubMed Web of Science ®Google Scholar
• Snee, L. S.; Nerurkar, V. R.; Dooley, D. A.; Efird, J. T.; Shovic, A. C.; Nerurkar, P. V. O. Strategies to Improve Palatability and Increase Consumption Intentions for Momordica Charantia (Bitter Melon): A Vegetable Commonly Used for Diabetes Management. Journal of Nutrition 2011, 10, 78. DOI:10.1186/1475-2891-10-78.
   Web of Science ®Google Scholar
• Martinez-Gonzalez, M. A.; Martin-Calvo, N. Mediterranean Diet and Life Expectancy; beyond Olive Oil, Fruits, and Vegetables. Current Opinion Clinical Nutrition Metabolism Care 2016, 19(6), 401–407. DOI: 10.1097/MCO.0000000000000316.
   PubMed Web of Science ®Google Scholar
• Aljohi, A.; Matou-Nasri, S.; Ahmed, N. Antiglycation and Antioxidant Properties of Momordica Charantia. PLoS One 2016, 11, e0159985. DOI:10.1371/journal.pone.0159985.
   PubMed Web of Science ®Google Scholar
• Dandawate, P. R.; Subramaniam, D.; Padhye, S. B.; Anant, S. Bitter Melon: A Panacea for Inflammation and Cancer. Chinese Journal of Natural Medicine 2016, 14(2), 81–100. DOI: 10.1016/S1875-5364(16)60002-X.
   PubMed Web of Science ®Google Scholar
• Alam, S.; Asad, M.; Asdaq, S. M.; Prasad, V. S. Antiulcer Activity of Methanolic Extract of Momordica Charantia L. In Rats. Journal of Ethnopharmacology 2009, 123(3), 464–469. DOI: 10.1016/j.jep.2009.03.024.
   PubMed Web of Science ®Google Scholar
• Tsai, C. H.; Chen, E. C.; Tsay, H. S.; Huang, C. J. Wild Bitter Gourd Improves Metabolic Syndrome: A Preliminary Dietary Supplementation Trial. Journal of Nutrition 2012, 11(1), 4. DOI: 10.1186/1475-2891-11-4.
   Web of Science ®Google Scholar
• Giovannini, P.; Howes, M. J.; Edwards, S. E. Medicinal Plants Used in the Traditional Management of Diabetes and Its Sequelae in Central America: Areview. Journal of Ethnopharmacology 2016, 184, 58–71. DOI:10.1016/j.jep.2016.02.034.
   PubMed Web of Science ®Google Scholar
• Nhiem, N. X.; Yen, P. H.; Ngan, N. T.; Quang, T. H.; Van-Kiem, P.; Van-Minh, C.; Tai, B. H.; Cuong, N. X.; Song, S. B.; Kim, Y. H. Inhibition of Nuclear Transcription Factor-κB and Activation of Peroxisome Proliferator-Activated Receptors in HepG2 Cells by Cucurbitane-Type Triterpene Glycosides from Momordica Charantia. Journal of Medicine Food 2012. DOI:10.1089/jmf.2011.1766.
   PubMed Web of Science ®Google Scholar
• Anilakumar, K. R.; Kumar, G. P.; Ilaiyaraja, N. Nutritional, Pharmacological and Medicinal Properties of Momordica Charantia. International Journal of Food Science and Nutrition 2015, 4(1), 75–83. DOI: 10.11648/j.ijnfs.20150401.21.
   Google Scholar
• Saeed, F.; Pasha, I.; Anjum, F. M.; Sultan, M. T. Arabinoxylans and Arabinogalactans: A Comprehensive Treatise. Critical Reviews in Food Science and Nutrition 2011, 51, 467–476. DOI:10.1080/10408391003681418.
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi, B.; Kumar, G. S.; Salimath, P. V. Effect of Bitter Gourd and Spent Turmeric on Glycoconjugate Metabolism in Streptozotocin-Induced Diabetic Rats. Journal of Diabetes and Its Complications 2009, 23(1), 71–76. DOI: 10.1016/j.jdiacomp.2007.09.005.
   PubMed Web of Science ®Google Scholar
• Shih, C. C.; Lin, C. H.; Lin, W. L.; Wu, J. B. Momordica Charantia Extract on Insulin Resistance and the Skeletal Muscle GLUT4 Protein in Fructose-Fed Rats. Journal of Ethnopharmacology 2009, 123(1), 82–90. DOI: 10.1016/j.jep.2009.02.039.
   PubMed Web of Science ®Google Scholar
• Horax, R.; Hettiarachchy, N.; Over, K.; Chen, P.; Gbur, E. Extraction, Fractionation and Characterization of Bitter Melon Seed Proteins. Journal of Agricultural and Food Chemistry 2010, 58(3), 1892–1897. DOI: 10.1021/jf902903s.
   PubMed Web of Science ®Google Scholar
• Bakare, R. I.; Magbagbeola, O. A.; Akinwande, A. I.; Okunowo, O. W. Nutritional and Chemical Evaluation of Momordica Charantia. Journal of Medicinal Plants Research 2010, 4, 2189–2193.
   Google Scholar
• Grossmann, M. E.; Mizuno, N. K.; Dammen, M. L.; Schuster, T.; Ray, A.; Cleary, M. P. Eleostearic Acid Inhibits Breast Cancer Proliferation by Means of an Oxidation-Dependent Mechanism. Cancer Prevention Research 2009, 2(10), 879–886. DOI: 10.1158/1940-6207.CAPR-09-0088.
   PubMed Web of Science ®Google Scholar
• Liu, X. R.; Deng, Z. Y.; Fan, Y. W.; Li, J.; Liu, Z. H. Mineral Elements Analysis of Momordica Charantiap Seeds by ICP-AES and Fatty Acid Profile Identification of Seed Oil by GC-MS. Guang Pu Xue Yu Guang Pu Fen Xi. 2010, 30(8), 2265–2268.
   PubMedGoogle Scholar
• Ibrahim, T. A.; El-Hefnawy, H. M.; El-Hela, A. A. Antioxidant Potential and Phenolic Acid Content of Certain Cucurbitaceous Plants Cultivated in Egypt. Natural Product Research 2010, 24(16), 1537–1545. DOI: 10.1080/14786419.2010.489049.
   PubMed Web of Science ®Google Scholar
• Yadav, M.; Lavania, A.; Tomar, R.; Prasad, G. B.; Jain, S.; Yadav, H. Complementary and Comparative Study on Hypoglycemic and Antihyperglycemic Activity of Various Extracts of Eugenia Jambolana Seed, Momordica Charantia Fruits, Gymnema Sylvestre, and Trigonella Foenum Graecum Seeds in Rats. Biotechnology and Applied Biochemistry 2010, 160(8), 2388–2400. DOI: 10.1007/s12010-009-8799-1.
   Web of Science ®Google Scholar
• Tan, S. P.; Stathopoulos, C.; Parks, S.; Roach, P. An Optimised Aqueous Extract of Phenolic Compounds from Bitter Melon with High Antioxidant Capacity. Antioxidants (Basel) 2014, 3(4), 814–829. DOI: 10.3390/antiox3040814.
   PubMedGoogle Scholar
• Popovich, D. G.; Li, L.; Zhang, W. Bitter Melon (Momordica Charantia) Triterpenoid Extract Reduces Preadipocyte Viability, Lipid Accumulation and Adiponectin Expression in 3T3-L1 Cells. Food and Chemical Toxicology 2010, 48(6), 1619–1626. DOI: 10.1016/j.fct.2010.03.035.
   PubMed Web of Science ®Google Scholar
• Mesia, G. K.; Tona, G. L.; Nanga, T. H.; Cimanga, R. K.; Apers, S.; Cos, P.; Maes, L.; Pieters, L.; Vlietinck, A. J. Antiprotozoal and Cytotoxic Screening of 45 Plant Extracts from Democratic Republic of Congo. Journal of Ethnopharmacology 2008, 115(3), 409–415. DOI: 10.1016/j.jep.2007.10.028.
   PubMed Web of Science ®Google Scholar
• Ahmad, Z.; Zamhuri, K. F.; Yaacob, A.; Siong, C. H.; Selvarajah, M.; Nazrul, I. A.; Hakim, M. In Vitro Anti-Diabetic Activities and Chemical Analysis of Polypeptide-K and Oil Isolated from Seeds of Momordica Charantia (Bitter Gourd). Molecules 2012, 17(8), 9631–9640. DOI: 10.3390/molecules17089631.
   PubMed Web of Science ®Google Scholar
• Hsu, C.; Hsieh, C. L.; Kuo, Y. H.; Huang, C. J. Isolation and Identification of Cucurbitane-Type Triterpenoids with Partial Agonist/Antagonist Potential for Estrogen Receptors from Momordica Charantia. Journal of Agricultural and Food Chemistry 2011, 59(9), 4553–4561. DOI: 10.1021/jf200418g.
   PubMed Web of Science ®Google Scholar
• Paul, A.Raychaudhuri, S.S. Medicinal Uses and Molecular Identification Of Two Momordia Charantia Varieties- a Review. Electronic Journal Of Biology 2010, 6(2),43-51.
   Google Scholar
• Kumar, R.; Balaji, S.; Sripriya, R.; Nithya, N.; Uma, T. S.; Sehgal, P. K. In Vitro Evaluation of Antioxidants of Fruit Extract of Momordica Charantia L. On Fibroblasts and Keratinocytes. Journal of Agricultural and Food Chemistry 2010, 58(3), 1518–1522. DOI: 10.1021/jf9025986.
   PubMed Web of Science ®Google Scholar
• Gudr, A. Influence of Total Anthocyanins from Bitter Melon (Momordica Charantia Linn.) As Antidiabetic and Radical Scavenging Agents. Iran Journal of Pharmacy Research 2016, 15(1), 301–309.
   PubMed Web of Science ®Google Scholar
• Poolperm, S.; Jiraungkoorskul, W. An Update Review on the Antithelmintic Activity of Bitter Gourd, Momordica Charantia. Pharmacognosy Reviews 2017, 11(21), 31–34. DOI: 10.4103/phrev.phrev_52_16.
   PubMedGoogle Scholar
• Preuss, H. G.; Echard, B.; Clouatre, D.; Bagchi, D.; Perricone, N. V. Niacin-Bound Chromium Increases Life Span in Zucker Fatty Rats. Inorganic Chemistry 2011, 105(10), 1344–1349.
   Google Scholar
• Zhang, B.; Xie, C.; Wei, Y.; Li, J.; Yang, X. Purification and Characterisation of an Antifungal Protein, MCha-Pr, from the Intercellular Fluid of Bitter Gourd (Momordica Charantia) Leaves. Protein Express Purification 2015, 107, 43–49. DOI:10.1016/j.pep.2014.09.008.
   PubMed Web of Science ®Google Scholar
• Jiang, B.; Ji, M.; Liu, W.; Chen, L.; Cai, Z.; Zhao, Y.; Bi, X. Antidiabetic Activities of a Cucurbitane Type Triterpenoid Compound from Momordica Charantia in Alloxan Induced Diabetic Mice. Molecular Medicine Reports 2016. DOI:10.3892/mmr.2016.5800.
   Web of Science ®Google Scholar
• Naz, R.; Anjum, F. M.; Butt, M. S.; Mahr-Un-Nisa. Dietary Supplementation of Bitter Gourd Reduces the Risk of Hypercholesterolemia in Cholesterol Fed Sprague Dawley Rats. Pakistan Journal of Pharmaceutical Sciences 2016, 29(5), 1565–1570.
   PubMed Web of Science ®Google Scholar
• Dia, V. P.; Krishnan, H. B. BG-4, a Novel Anticancer Peptide from Bitter Gourd (Momordica Charantia), Promotes Apoptosis in Human Colon Cancer Cells. Scientific Reports 2016, 15(6), 332–335.
   Google Scholar
• Nerurkar, P. V.; Johns, L. M.; Buesa, L. M.; Kipyakwai, G.; Volper, E.; Sato, R.; Shah, P.; Feher, D.; Williams, P. G.; Nerurkar, V. R. Momordica Charantia (Bitter Melon) Attenuates High-Fat Diet-Associated Oxidative Stress and Neuroinflammation. Journal of Inflammation 2011, 8, 64.
   Google Scholar
• Zhu, Y.; Bai, J.; Zhang, Y.; Xiao, X.; Dong, Y. Effects of Bitter Melon (Momordica Charantia L.) On the Gut Microbiota in High Fat Diet and Low Dose Streptozocin-Induced Rats. International Journal of Food Science and Nutrition 2016, 67(6), 686–695. DOI: 10.1080/09637486.2016.1197185.
   PubMed Web of Science ®Google Scholar
• Babish, J. G.; Paciorett, L. M.; Bland, J. S.; Minich, D. M.; Hu, J.; Tripp, M. L. Antidiabetic Screening of Commercial Botanical Products in 3T3-L1 Adipocytes and Db/Db Mice. Journal of Medical Food 2012, 13(3), 535–547. DOI: 10.1089/jmf.2009.0110.
   Web of Science ®Google Scholar
• Chaturvedi, P. Antidiabetic Potentials of Momordica Charantia: Multiple Mechanisms behind the Effects. Journal of Medical Food 2012, 15(2), 101–107. DOI: 10.1089/jmf.2010.0258.
   PubMed Web of Science ®Google Scholar
• Yousaf, S.; Hussain, A.; Rehman, S.; Aslam, M. S.; Abbas, Z. Hypoglycemic and Hypolipidemic Effects of Lactobacillus Fermentum, Fruit Extracts of Syzygium Cumini and Momordica Charantia on Diabetes Induced Mice. Pakistan Journal of Pharmaceutical Sciences 2016, 29(5), 1535–1540.
   PubMed Web of Science ®Google Scholar
• Akhtar, N.; Khan, B. A.; Majid, A.; Khan, H. M.; Mahmood, T.; Gulfishan,; Saeed, T. Pharmaceutical and Biopharmaceutical Evaluation of Extracts from Different Plant Parts of Indigenous Origin for Their Hypoglycemic Responses in Rabbits. Acta Poloniae Pharmaceutica 2011, 68(6), 919–925.
   PubMed Web of Science ®Google Scholar
• Sridhar, M. G.; Vinayagamoorthi, R.; Arul-Suyambunathan, V.; Bobby, Z.; Selvaraj, N. Bitter Gourd (Momordica Charantia) Improves Insulin Sensitivity by Increasing Skeletal Muscle Insulin-Stimulated IRS-1 Tyrosine Phosphorylation in High-Fat-Fed Rats. British Journal of Nutrition 2008, 99(4), 806–812. DOI: 10.1017/S000711450783176X.
   PubMed Web of Science ®Google Scholar
• Klomann, S. D.; Mueller, A. S.; Pallauf, J.; Krawinkel, M. B. Antidiabetic Effects of Bitter Gourd Extracts in Insulin-Resistant Db/Db Mice. British Journal of Nutrition 2010, 104(11), 1613–1620. DOI: 10.1017/S0007114510002680.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, P.; George, S. Momordica Charantia Maintains Normal Glucose Levels and Lipid Profiles and Prevents Oxidative Stress in Diabetic Rats Subjected to Chronic Sucrose Load. Journal of Medical Food. 2010, 13(3), 520–527. DOI: 10.1089/jmf.2009.0151.
   PubMed Web of Science ®Google Scholar
• Dar, U. K.; Owais, F.; Ahmad, M.; Rizwani, G. H. Biochemical Analysis of the Crude Extract of Momordica Charantia (L.). Pakistan Journal of Pharmaceutical Sciences 2014, 27(6), 2237–2240.
   PubMed Web of Science ®Google Scholar
• Wang, B. L.; Zhang, W. J.; Zhao, J.; Wang, F. J.; Fan, L. Q.; Wu, Y. X.; Hu, Z. B. Gene Cloning and Expression of a Novel Hypoglycemic Peptide from Momordica Charantia. Journal of the Science of Food and Agriculture 2010, 91(13), 2443–2448. DOI: 10.1002/jsfa.4485.
   Web of Science ®Google Scholar
• Singh, N.; Gupta, M.; Sirohi, P.; Varsha, R. Effects of Alcoholic Extract of Momordica Charantia (Linn.) Whole Fruit Powder on the Pancreatic Islets of Alloxan Diabetic Albino Rats. Journal of Environmental Biology 2008, 29(1), 101–106.
   PubMed Web of Science ®Google Scholar
• Poovitha, S.; Parani, M. In Vitro and in Vivo α-amylase and α-glucosidase Inhibiting Activities of the Protein Extracts from Two Varieties of Bitter Gourd (Momordica Charantia L.). BMC Complementary and Alternative Medicine 2016, 16(1), 185. DOI: 10.1186/s12906-016-1085-1.
   PubMed Web of Science ®Google Scholar
• Nivitabishekam, S. N.; Asad, M.; Prasad, V. S. Pharmacodynamic Interaction of Momordica Charantia with Rosiglitazone in Rats. Chemico–Biological Interactions 2009, 177(3), 247–253. DOI: 10.1016/j.cbi.2008.09.034.
   PubMed Web of Science ®Google Scholar
• Han, C.; Hui, Q.; Wang, Y. Hypoglycaemic Activity of Saponin Fraction Extracted from Momordica Charantia in PEG/salt Aqueous Two-Phase Systems. Natural Products Research 2008, 22(13), 1112–1119. DOI: 10.1080/14786410802079675.
   PubMed Web of Science ®Google Scholar
• Kasbia, G. S.; Arnason, J. T.; Imbeault, P. No Effect of Acute, Single Dose Oral Administration of Momordica Charantia Linn., On Glycemia, Energy Expenditure and Appetite: A Pilot Study in Non-Diabetic Overweight Men. Journal of Ethnopharmacology 2009, 126(1), 127–330. DOI: 10.1016/j.jep.2009.07.035.
   PubMed Web of Science ®Google Scholar
• Singh, N.; Gupta, M. Regeneration of Beta Cells in Islets of Langerhans of Pancreas of Alloxan Diabetic Rats by Acetone Extract of Momordica Charantia (Linn.) (Bitter Gourd) Fruits. Indian Journal of Experimental Biology 2007, 45(12), 1055–1062.
   PubMed Web of Science ®Google Scholar
• Keller, A. C.; Ma, J.; Kavalier, A.; He, K.; Brillantes, A. M.; Kennelly, E. J. Saponins from the Traditional Medicinal Plant Momordica Charantia Stimulate Insulin Secretion in Vitro. Phytomedicine 2011, 19(1), 32–37. DOI: 10.1016/j.phymed.2011.06.019.
   PubMed Web of Science ®Google Scholar
• Abdollahi, M.; Zuki, A. B.; Goh, Y. M.; Rezaeizadeh, A.; Noordin, M. M. Effects of Momordica Charantia on Pancreatic Histopathological Changes Associated with Streptozotocin-Induced Diabetes in Neonatal Rats. Histol. Histopathol. 2011, 26(1), 13–21.
   PubMed Web of Science ®Google Scholar
• Malik, Z. A.; Singh, M.; Sharma, P. L. Neuroprotective Effect of Momordica Charantia in Global Cerebral Ischemia and Reperfusion Induced Neuronal Damage in Diabetic Mice. Journal of Ethnopharmacology 2011, 133(2), 729–734. DOI: 10.1016/j.jep.2010.10.061.
   PubMed Web of Science ®Google Scholar
• Wei, L.; Shaoyun, W.; Shutao, L.; Jianwu, Z.; Lijing, K.; Pingfan, R. Increase in the Free Radical Scavenging Capability of Bitter Gourd by a Heat-Drying Process. Journal of Functional Foods 2013, 4(12), 1850–1855. DOI: 10.1039/c3fo60169b.
   Web of Science ®Google Scholar
• Hafizur, R. M.; Kabir, N.; Chishti, S. Modulation of Pancreatic β-cells in Neonatally Streptozotocin-Induced Type 2 Diabetic Rats by the Ethanolic Extract of Momordica Charantia Fruit Pulp. Natural Product Research 2011, 25(4), 353–367. DOI: 10.1080/14786411003766904.
   PubMed Web of Science ®Google Scholar
• Nerurkar, P. V.; Lee, Y. K.; Motosue, M.; Adeli, K.; Nerurkar, V. R. Momordica Charantia (Bitter Melon) Reduces Plasma Apolipoprotein B-100 and Increases Hepatic Insulin Receptor Substrate and Phosphoinositide-3 Kinase Interactions. British Journal of Nutrition 2008, 100(4), 751–759. DOI: 10.1017/S0007114508937430.
   PubMed Web of Science ®Google Scholar
• Lo, H. Y.; Li, C. C.; Ho, T. Y.; Hsiang, C. Y. Identification of the Bioactive and Consensus Peptide Motif from Momordica Charantia Insulin Receptor-Binding Protein. Food Chemistry 2016. DOI:10.1016/j.foodchem.2016.02.135.
   PubMed Web of Science ®Google Scholar
• Choudhary, S. K.; Chhabra, G.; Sharma, D.; Vashishta, A.; Ohri, S.; Dixit, A. Comprehensive Evaluation of Anti-Hyperglycemic Activity of Fractionated Momordica Charantia Seed Extract in Alloxan-Induced Diabetic Rats. Electronic Publication 2012, 29, 36–50.
   Google Scholar
• Hall, J. E.; Do Carmo, J. M.; Da Silva, A. A.; Wang, Z.; Hall, M. E. Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms. Circular Research 2015, 116(6), 991–1006. DOI: 10.1161/CIRCRESAHA.116.305697.
   PubMed Web of Science ®Google Scholar
• Fang, E. F.; Ng, T. B. Bitter Gourd (Momordica Charantia) Is A Cornucopia of Health: A Review of Its Credited Antidiabetic, anti-HIV, and Antitumor Properties. Current Molecular Medicine 2011, 11(5), 417–436. DOI: 10.2174/156652411795976583.
   PubMed Web of Science ®Google Scholar
• Bouret, S.; Levin, B. E.; Ozanne, S. E. Gene-Environment Interactions Controlling Energy and Glucose Homeostasis and the Developmental Origins of Obesity. Physiological Reviews 2015, 95(1), 47–82. DOI: 10.1152/physrev.00007.2014.
   PubMed Web of Science ®Google Scholar
• Blum, A.; Loerz, C.; Martin, H. J.; Staab-Weijnitz, C. A.; Maser, E. Momordica Charantia Extract, a Herbal Remedy for Type 2 Diabetes, Contains a Specific 11β-hydroxysteroid Dehydrogenase Type 1 Inhibitor. Journal of Steroid Biochemistry and Molecular Biology 2012, 128(1–2), 51–55. DOI: 10.1016/j.jsbmb.2011.09.003.
   PubMed Web of Science ®Google Scholar
• Kumar, G. S.; Shetty, A. K.; Salimath, P. V. Modulatory Effect of Bitter Gourd (Momordica Charantia LINN.) On Alterations in Kidney Heparan Sulfate in Streptozotocin-Induced Diabetic Rats. Journal of Ethnopharmacology 2008, 115(2), 276–283. DOI: 10.1016/j.jep.2007.10.002.
   PubMed Web of Science ®Google Scholar
• Efird, J. T.; Choi, Y. M.; Davies, S. W.; Mehra, S.; Anderson, E. J.; Katunga, L. A. Potential for Improved Glycemic Control with Dietary Momordica Charantia in Patients with Insulin Resistance and Pre-Diabetes. Int. J. Environ. Res. Public Health 2014, 11(2), 2328–2345. DOI: 10.3390/ijerph110202328.
   PubMed Web of Science ®Google Scholar
• Saha, S. S.; Chakraborty, A.; Ghosh, S.; Ghosh, M. Comparative Study of Hypocholesterolemic and Hypolipidemic Effects of Conjugated Linolenic Acid Isomers against Induced Biochemical Perturbations and Aberration in Erythrocyte Membrane Fluidity. European Journal of Nutrition 2011, 51(4), 483–495.
   PubMed Web of Science ®Google Scholar
• Cao, H.; Sethumadhavan, K.; Grimm, C. C.; Ullah, A. H. J. Characterization of a Soluble Phosphatidic Acid Phosphatase in Bitter Melon (Momordica Charantia). PLoS One 2014, 9(9), 106–113. DOI: 10.1371/journal.pone.0106403.
   Web of Science ®Google Scholar
• Joseph, B.; Jini, D. Antidiabetic Effects of Momordica Charantia (Bitter Melon) and Its Medicinal Potency. Asian Pacific Journal of Tropical Biomedical 2013, 3(2), 93–102. DOI: 10.1016/S2222-1808(13)60052-3.
   Google Scholar
• Guo, T.; Zhu, L.; Tan, J.; Zhou, X.; Xiao, L.; Liu, X.; Wang, B. Promoting Effect of Triterpenoid Compound from Agrimonia pilosaLedeb on Preadipocytes Differentiation via Up-Regulation of PPARγ Expression. Pharmacognosy Magazine 2015, 11(41), 219–225. DOI: 10.4103/0973-1296.149741.
   PubMed Web of Science ®Google Scholar
• Wang, J.; Ryu, H. K. The Effects of Momordica Charantia on Obesity and Lipid Profiles of Mice Fed a High-Fat Diet. Nutrition Research Practice 2015, 9(5), 489–495. DOI: 10.4162/nrp.2015.9.5.489.
   PubMed Web of Science ®Google Scholar
• Zhu, Y.; Dong, Y.; Qian, X.; Cui, F.; Guo, Q.; Zhou, X.; Wang, Y.; Zhang, Y.; Xiong, Z. Effect of Superfine Grinding on Antidiabetic Activity of Bitter Melon Powder. International Journal of Molecular Sciences 2012, 13(11), 14203–14218. DOI: 10.3390/ijms131114203.
   PubMed Web of Science ®Google Scholar
• Ahmed, D.; Kumar, V.; Verma, A.; Gupta, P.; Kumar, H.; Dhingra, V.; Mishra, V.; Sharma, M. Antidiabetic, Renal/Hepatic/Pancreas/Cardiac Protective and Antioxidant Potential of Methanol/Dichloromethane Extract of Albizzia Lebbeck Benth. Stem Bark (Alex) on Streptozotocin Induced Diabetic Rats. BMC Complementary and Alternative Medicine 2014, 14, 243. DOI:10.1186/1472-6882-14-243.
   PubMed Web of Science ®Google Scholar
• Teoh, S. L.; Abd-Latiff, A.; Das, S. Histological Changes in the Kidneys of Experimental Diabetic Rats Fed with Momordica Charantia (Bitter Gourd) Extract. International Journal of Insect Morphology and Embryology 2010, 51(1), 91–95.
   Google Scholar
• Raish, M.; Ahmad, A.; Jan, B. L.; Alkharfy, K. M.; Ansari, M. A.; Mohsin, K.; Jenoobi, F. A.; Al-Mohizea, A. Momordica Charantia Polysaccharides Mitigate the Progression of STZ Induced Diabetic Nephropathy in Rats. International Journal of Biological Macromolecules 2016, 91, 394–399. DOI:10.1016/j.ijbiomac.2016.05.090.
   PubMed Web of Science ®Google Scholar
• Uebanso, T.; Arai, H.; Taketani, Y.; Fukaya, M.; Yamamoto, H.; Mizuno, A.; Uryu, K.; Hada, T.; Takeda, E. Chemical Composition and Antimicrobial Activity of Momordica Charantia Seed Essential Oil. Fitoterapia 2008, 79(2), 123–125. DOI: 10.1016/j.fitote.2007.11.002.
   PubMed Web of Science ®Google Scholar
• Matsui, S.; Yamane, T.; Takita, T.; Oishi, Y.; Kobayashi-Hattori, K. The Hypocholesterolemic Activity of Momordica Charantia Fruit Is Mediated by the Altered Cholesterol- and Bile Acid-Regulating Gene Expression in Rat Liver. Nutrition Research 2013, 33(7), 580–585. DOI: 10.1016/j.nutres.2013.05.002.
   PubMed Web of Science ®Google Scholar
• Boone, C. H.; Stout, J. A.; Gordon, J. A.; Redd, M. J.; Church, D. D.; Oliveira, L. P.; Fukuda, D. H.; Hoffman, J. R. Acute Effects of a Beverage Containing Bitter Melon Extract (CARELA) on Postprandial Glycemia among Prediabetic Adults. Nutrition Diabetes 2017, 7, e24. DOI:10.1038/nutd.2016.51.
   Web of Science ®Google Scholar
• Raina, K.; Kumar, D.; Agarwal, R. Promise of Bitter Melon (Momordica Charantia) Bioactives in Cancer Prevention and Therapy. Seminars Cancer Biology 2016, 40, 116–129. DOI:10.1016/j.semcancer.2016.07.002.
   PubMed Web of Science ®Google Scholar
• Nerurkar, P. V.; Lee, Y. K.; Nerurkar, V. R. Momordica Charantia (Bitter Melon) Inhibits Primary Human Adipocyte Differentiation by Modulating Adipogenic Genes. BMC Complementary and Alternative Medicine 2010, 10, 34. DOI:10.1186/1472-6882-10-34.
   PubMed Web of Science ®Google Scholar
• Kabir, S. R.; Nabi, M. M.; Nurujjaman, M.; Abu Reza, M.; Alam, A. H.; Uz Zaman, R.; Khalid-Bin-Ferdaus, K. M.; Amin, R.; Khan, M. M.; Hossain, M. A.; et al. Momordica Charantia Seed Lectin: Toxicity, Bacterial Agglutination and Antitumor Properties. Biotechnology and Applied Biochemistry 2015, 175(5), 2616–2628. DOI:10.1007/s12010-014-1449-2.
   Web of Science ®Google Scholar
• Fan, X.; He, L.; Meng, Y.; Li, G.; Li, L.; Meng, Y. Α-MMC and MAP30, Two Ribosome-Inactivating Proteins Extracted from Momordica Charantia, Induce Cell Cycle Arrest and Apoptosis in A549 Human Lung Carcinoma Cells. Molecular Medicine Reports 2015, 11(5), 3553–3558. DOI: 10.3892/mmr.2015.3176.
   PubMed Web of Science ®Google Scholar
• Muhammad, N.; Steele, R.; Isbell, T. S.; Philips, N.; Ray, R. B. Bitter Melon Extract Inhibits Breast Cancer Growth in Preclinical Model by Inducing Autophagic Cell Death. Oncotarget 2017, 8(39), 66226–66236. DOI: 10.18632/oncotarget.19887.
   PubMedGoogle Scholar
• Pitchakarn, P.; Suzuki, S.; Ogawa, K.; Pompimon, W.; Takahashi, S.; Asamoto, M.; Limtrakul, P.; Shirai, T.; Kuguacin, J. A Triterpeniod from Momordica Charantia Leaf, Modulates the Progression of Androgen-Independent Human Prostate Cancer Cell Line, PC3. Food and Chemical Toxicology 2012. DOI:10.1016/j.fct.2012.01.009.
   PubMed Web of Science ®Google Scholar
• Białek, A.; Teryks, M.; Tokarz, A. Conjugated Linolenic Acids (Clna, Super CLA)–Natural Sources and Biological Activity. Postępy Higieny I Medycyny Doświadczalnej 2014, 68, 1238–1250. DOI:10.5604/17322693.1127881.
   Web of Science ®Google Scholar
• Kupradinun, P.; Tepsuwan, A.; Tantasi, N.; Meesiripun, N.; Rungsipipat, A.; Kusamran, W. R. Anticlastogenic and Anticarcinogenic Potential of Thai Bitter Gourd Fruits. Asian Pacific Journal of Cancer Prevention 2011, 12(5), 1299–1305.
   PubMedGoogle Scholar
• Pitchakarn, P.; Suzuki, S.; Ogawa, K.; Pompimon, W.; Takahashi, S.; Asamoto, M.; Limtrakul, P.; Shirai, T. A. Induction of G1 Arrest and Apoptosis in Androgen-Dependent Human Prostate Cancer by Kuguacin J, a Triterpenoid from Momordica Charantia Leaf. Cancer Letters 2011, 306(2), 142–150. DOI: 10.1016/j.canlet.2011.02.041.
   PubMed Web of Science ®Google Scholar
• Brennan, V. C.; Wang, C. M.; Yang, W. H. Bitter Melon (Momordica Charantia) Extract Suppresses Adrenocortical Cancer Cell Proliferation through Modulation of the Apoptotic Pathway, Steroidogenesis, and Insulin-Like Growth Factor Type 1 receptor/RAC-α Serine/Threonine-Protein Kinase Signaling. Journal of Medical Food. 2012, 15(4), 325–334. DOI: 10.1089/jmf.2011.0158.
   PubMed Web of Science ®Google Scholar
• Brennan, V. C.; Wang, C. M.; Yang, W. H. Bitter Melon (Momordica Charantia) Extract Suppresses Adrenocortical Cancer Cell Proliferation through Modulation of the Apoptotic Pathway, Steroidogenesis, and Insulin-Like Growth Factor Type 1 Receptor/RAC-α Serine/Threonine-Protein Kinase Signaling. Journal of Medical Foods 2011.
   PubMed Web of Science ®Google Scholar
• Weng, J. R.; Bai, L. Y.; Chiu, C. F.; Hu, J. L.; Chiu, S. J.; Wu, C. Y. Cucurbitane Triterpenoid from Momordica Charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation. Evidence-Based Complementary and Alternative Medicine 2013, 12. Article ID 935675. http://dx.doi.org/10.1155/2013/935675
   Web of Science ®Google Scholar
• Meng, Y.; Liu, B.; Lei, N.; Zheng, J.; He, Q.; Li, D.; Zhao, X.; Shen, F. Alpha-Momorcharin Possessing High Immunogenicity, Immunotoxicity and Hepatotoxicity in SD Rats. Journal of Ethnopharmacology 2012, 139(2), 590–598. DOI: 10.1016/j.jep.2011.11.057.
   PubMed Web of Science ®Google Scholar
• Kai, H.; Akamatsu, E.; Torii, E.; Kodama, H.; Yukizaki, C.; Akagi, I.; Ino, H.; Sakakibara, Y.; Suiko, M.; Yamamoto, I.; et al. Identification of a Bioactive Compound against Adult T-Cell Leukaemia from Bitter Gourd Seeds. Plants (Basel) 2013, 3(1), 18–26. DOI:10.3390/plants3010018.
   PubMedGoogle Scholar
• Mondal, J.; Samadder, A.; Khuda-Bukhsh, A. R. Psorinum 6 × Triggers Apoptosis Signals in Human Lung Cancer Cells. Journal Integrative Biomedical 2016, 14(2), 143–153. DOI: 10.1016/S2095-4964(16)60230-3.
   PubMed Web of Science ®Google Scholar
• Zhuo, R. J.; Wang, F.; Zhang, X. H.; Zhang, J. J.; Xu, J.; Dong, W.; Zou, Z. Q. Α-Eleostearic Acid Inhibits Growth and Induces Apoptosis in Breast Cancer Cells via HER2/HER3 Signaling. Molecular Medicine Reports 2014, 9(3), 993–998. DOI: 10.3892/mmr.2014.1892.
   PubMed Web of Science ®Google Scholar
• Fang, E. F.; Zhang, C. Z.; Ng, T. B.; Wong, J. H.; Pan, W. L.; Ye, X. J.; Chan, Y. S.; Fong, W. P. Momordica Charantia Lectin, a Type II Ribosome Inactivating Protein, Exhibits Antitumor Activity toward Human Nasopharyngeal Carcinoma Cells in Vitro and in Vivo. Cancer Prevention Research 2012, 5(1), 109–121. DOI: 10.1158/1940-6207.CAPR-11-0203.
   PubMed Web of Science ®Google Scholar
• Pan, W. L.; Wong, J. H.; Fang, E. F.; Chan, Y. S.; Ng, T. B.; Cheung, R. C. Preferential Cytotoxicity of the Type I Ribosome Inactivating Protein Alpha-Momorcharin on Human Nasopharyngeal Carcinoma Cells under Normoxia and Hypoxia. Pharmacology Biochemistry Behavior 2014, 89(3), 329–339. DOI: 10.1016/j.bcp.2014.03.004.
   Web of Science ®Google Scholar
• Ray, R. B.; Raychoudhuri, A.; Steele, R.; Nerurkar, P. Bitter Melon (Momordica Charantia) Extract Inhibits Breast Cancer Cell Proliferation by Modulating Cell Cycle Regulatory Genes and Promotes Apoptosis. Cancer Research 2010, 70(5), 1925–1931. DOI: 10.1158/0008-5472.CAN-09-3438.
   PubMed Web of Science ®Google Scholar
• Kobori, M.; Nakayama, H.; Fukushima, K.; Ohnishi-Kameyama, M.; Ono, H.; Fukushima, T.; Akimoto, Y.; Masumoto, S.; Yukizaki, C.; Hoshi, Y.; et al. Bitter Gourd Suppresses Lipopolysaccharide-Induced Inflammatory Responses. Journal of Agricultural and Food Chemistry 2008, 56(11), 4004–4011. DOI:10.1021/jf800052y.
   PubMed Web of Science ®Google Scholar
• Suknuntha, K.; Thita, T.; Togarrati, P. P.; Ratanachamnong, P.; Wongtrakoongate, P.; Srihirun, S.; Slukvin, I.; Hongeng, S. Wnt Signaling Inhibitor FH535 Selectively Inhibits Cell Proliferation and Potentiates Imatinib-Inducedapoptosis in Myeloid Leukemia Cell Lines. International Journal of Hematology 2016, 105(2), 196–205.
   PubMed Web of Science ®Google Scholar
• Guan, L. Synthesis and Anti-Tumour Activities of Sulphated Polysaccharide Obtained from Momordica Charantia. Natural Products Research 2012, 26(14), 1303–1309. DOI: 10.1080/14786419.2011.571214.
   PubMed Web of Science ®Google Scholar
• Xiong, S. D.; Yu, K.; Liu, X. H.; Yin, L. H.; Kirschen. Baum, A.; Yao, S.; Narla, G.; DiFeo, A.; Wu, J. B.; Yuan, Y.; et al. Ribosome-Inactivating Proteins Isolated from Dietary Bitter Melon Induce Apoptosis and Inhibit Histone Deacetylase-1 Selectively in Premalignant and Malignant Prostate Cancer Cells. International Journal of Cancer. 2009, 125(4), 774–782. DOI:10.1002/ijc.24325.
   PubMed Web of Science ®Google Scholar
• Chen, J.; Zheng, Z.; Chen, Y.; Li, J.; Qian, S.; Shi, Y.; Sun, L.; Han, Y.; Zhang, S.; Yu, K. Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα. PLoS One 2016, 11(4), 15–33.
   Web of Science ®Google Scholar
• Agrawal, R. C.; Beohar, T. Chemo Preventive and Ant Carcinogenic Effects of Momordica Charantia Extract. Asian Pacific Journal of Cancer Prevention 2010, 11(2), 371–375.
   PubMedGoogle Scholar
• Pitchakarn, P.; Ohnuma, S.; Pintha, K.; Pompimon, W.; Ambudkar, S. V.; Limtrakul, P. B. Kuguacin J Isolated from Momordica Charantia Leaves Inhibits P-Glycoprotein (Abcb1)-Mediated Multidrug Resistance. Journal of Nutritional Biochemistry 2011, 23(1), 76–84. DOI: 10.1016/j.jnutbio.2010.11.005.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, S.; Muhammad, N.; Steele, R.; Kornbluth, J.; andRay, R.B. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells. Cancer Prevention Research 2017. DOI:10.1158/1940-6207.CAPR-17-0046.
   Web of Science ®Google Scholar
• Yang, S. J.; Choi, J. M.; Park, S. E.; Rhee, E. J.; Lee, W. Y.; Oh, K. W.; Park, S. W.; Park, C. Y. Preventive Effects of Bitter Melon (Momordica Charantia) against Insulin Resistance and Diabetes are Associated with the Inhibition of NF-κB and JNK Pathways in High-Fat-Fed OLETF Rats. Journal of Nutritional Biochemistry 2015, 26(3), 234–240. DOI: 10.1016/j.jnutbio.2014.10.010.
   PubMed Web of Science ®Google Scholar
• Bai, J.; Zhu, Y.; Dong, Y. Response of Gut Microbiota and Inflammatory Status to Bitter Melon (Momordica Charantia L.) In High Fat Diet Induced Obese Rats. Journal of Ethnopharmacology 2016, 16, 378–387.
   Google Scholar
• Sato, M.; Ueda, T.; Nagata, K.; Shiratake, S.; Tomoyori, H.; Kawakami, M.; Ozaki, Y.; Okubo, H.; Shirouchi, B.; Imaizumi, K. Dietary Kakrol (Momordica Dioica Roxb.) Flesh Inhibits Triacylglycerol Absorption and Lowers the Risk for Development of Fatty Liver in Rats. Experimental Biology and Medicine 2011, 236(10), 1139–1146. DOI: 10.1258/ebm.2011.011037.
   Web of Science ®Google Scholar
• Chao, C. Y.; Sung, P. J.; Wang, W. H.; Kuo, Y. H. Anti-Inflammatory Effect of Momordica Charantia in Sepsis Mice. Molecules 2014, 19(8), 12777–12788. DOI: 10.3390/molecules190812777.
   PubMed Web of Science ®Google Scholar
• Chen, C. R.; Liao, Y. W.; Wang, L.; Kuo, Y. H.; Liu, H. J.; Shih, W. L.; Cheng, H. L.; Chang, C. I. Cucurbitane Triterpenoids from Momordica Charantia and Their Cytoprotective Activity in Tert-Butyl Hydroperoxide-Induced Hepatotoxicity of HepG2 Cells. Chemical and Pharmaceutical Bulletin 2010, 58(12), 1639–1642. DOI: 10.1248/cpb.58.1639.
   PubMed Web of Science ®Google Scholar
• Saad, D. Y.; Soliman, M. M.; Baiomy, A. A.; Yassin, M. H.; El-Sawy, H. B. Effects of Karela (Bitter Melon; Momordica Charantia) on Genes of Lipids and Carbohydrates Metabolism in Experimental Hypercholesterolemia: Biochemical, Molecular and Histopathological Study. Experimental Biology and Medicine 2017, 17, 319. DOI:10.1186/s12906-017-1833-x.
   Web of Science ®Google Scholar
• Mahwish, S. F.; Arshad, M. S.; Nisa, M. U. L.; Nadeem, M. T.; Arshad, M. U. Hypoglycemic and Hypolipidemic Effects of Different Parts and Formulations of Bitter Gourd (Momordica Charantia). Lipids Health Disease 2017. DOI:10.1186/s12944-017-0602-7.
   PubMed Web of Science ®Google Scholar
• Thenmozhi, A. J.; Subramanian, P. Antioxidant Potential of Momordica Charantia in Ammonium Chloride-Induced Hyperammonemic Rats. Evidence-Based Complementary and Alternative Medicine 2012, 2011, 7. Article ID 612023, http://dx.doi.org/10.1093/ecam/nep227.
   Web of Science ®Google Scholar
• Sagor, A. T.; Chowdhury, M. R.; Tabassum, N.; Hossain, H.; Rahman, M. M.; Alam, M. A. Supplementation of Fresh Ucche (Momordica Charantia L. Var. Muricata Willd) Prevented Oxidative Stress, Fibrosis and Hepatic Damage in CCl4 Treated Rats. BMC Complementary and Alternative Medicine 2015, 15, 115. DOI:10.1186/s12906-015-0636-1.
   PubMed Web of Science ®Google Scholar
• Sinha, A. K.; AbdElgawad, H.; Zinta, G.; Dasan, A. F.; Rasoloniriana, R.; Asard, H.; Blust, R.; De Boeck, G. Nutritional Status as the Key Modulator of Antioxidant Responses Induced by High EnvironmentalAmmonia and Salinity Stress in European Sea Bass (Dicentrarchus Labrax). PLoS One. 2015, 10(8), e0135091. DOI: 10.1371/journal.pone.0135091.
   PubMed Web of Science ®Google Scholar
• Yadav, B. S.; Yadav, R.; Yadav, R. B.; Garg, M. Antioxidant Activity of Various Extracts of Selected Gourd Vegetables. Journal of Food Science 2016, 53(4), 1823–1833.
   Web of Science ®Google Scholar
• Kamal, R.; Yadav, S.; Mathur, M.; Katariya, P. Antiradical Efficiency of 20 Selected Medicinal Plants. Journal of Natural Products 2011, 26(11), 1054–1062.
   PubMed Web of Science ®Google Scholar
• Yehye, W. A.; Abdul Rahman, N.; Saad, O.; Ariffin, A.; Abd Hamid, S. B.; Alhadi, A. A.; Kadir, F. A.; Yaeghoobi, M.; Matlob, A. A. Rational Design and Synthesis of New, High Efficiency, Multipotent Schiff Base-1,2,4-triazoleAntioxidants Bearing Butylated Hydroxytoluene Moieties. Molecules 2016, 21(7), 84–87. DOI: 10.3390/molecules21070847.
   PubMed Web of Science ®Google Scholar
• Qader, S. W.; Abdulla, M. A.; Chua, L. S.; Najim, N.; Zain, M. M.; Hamdan, S. Antioxidant, Total Phenolic Content and Cytotoxicity Evaluation of Selected Malaysian Plants. Molecules. 2011, 16(4), 3433–3443. DOI: 10.3390/molecules16043433.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, P. Bitter Melon Protects against Lipid Peroxidation Caused by Immobilization Stress in Albino Rats. International Journal of Vitamin Nutrition Research 2009, 79(1), 48–56. DOI: 10.1024/0300-9831.79.1.48.
   PubMed Web of Science ®Google Scholar
• Alam, M. A.; Uddin, R.; Subhan, N.; Rahman, M. M.; Jain, P.; Reza, H. M. Beneficial Role of Bitter Melon Supplementation in Obesity and Related Complications in Metabolic Syndrome. Journal of Lipid Research 2015, 49, 61–69.
   Google Scholar
• Khan, S. R.; Aljuhani, N.; Morgan, A. G.; Baghdasarian, A.; Fahlman, R. P.; Siraki, A. G. Cytoprotective Effect of Isoniazid against H2O2 Derived Injury in HL-60 Cells. Chemical Biology Interactions 2016, 244, 37–48. DOI:10.1016/j.cbi.2015.11.026.
   PubMed Web of Science ®Google Scholar
• Padmashree, A.; Sharma, G. K.; Semwal, A. D.; Bawa, A. S. Studies on the Antioxygenic Activity of Bitter Gourd (Momordica Charantia) and Its Fractions Using Various in Vitro Models. Journal of the Science of Food and Agriculture 2011, 91(4), 776–782. DOI: 10.1002/jsfa.4251.
   PubMed Web of Science ®Google Scholar
• Shodehinde, S. A.; Adefegha, S. A.; Oboh, G.; Oyeleye, S. I.; Olasehinde, T. A.; Nwanna, E. E.; Adedayo, B. C.; Boligon, A. A. Phenolic Composition and Evaluation of Methanol and Aqueous Extracts of Bitter Gourd (Momordica Charantia L) Leaves on Angiotensin-I-Converting Enzyme and Some Pro-oxidant-Induced Lipid Peroxidation in Vitro. Evidence–Based Complementary and Alternative Medicine 2016, 21(4), 67–76. DOI: 10.1177/2156587216636505.
   Web of Science ®Google Scholar
• Liu, J. Q.; Chen, J. C.; Wang, C. F.; Qiu, M. H. New Cucurbitane Triterpenoids and Steroidal Glycoside from Momordica Charantia. Molecules 2009, 14(12), 4804–4813. DOI: 10.3390/molecules14124804.
   PubMed Web of Science ®Google Scholar
• Li, Y. C.; Xu, X. J.; Yang, J.; Wu., X. G.; Fu, Q. Y. One New 19-Nor Cucurbitane-Type Triterpenoid from the Stems of Momordica Charantia. Natural Product Research 2016, 30(8), 973–978. DOI: 10.1080/14786419.2015.1089241.
   PubMed Web of Science ®Google Scholar
• Fan, J. M.; Zhang, Q.; Xu, J.; Zhu, S.; Ke, T.; Gao-De, F.; Xu, Y. B. Inhibition on Hepatitis B Virus in Vitro of Recombinant MAP30 from Bitter Melon. Molecular Biology Reports 2009, 36(2), 381–388. DOI: 10.1007/s11033-007-9191-2.
   PubMed Web of Science ®Google Scholar
• Liu, C.; Cai, D.; Zhang, L.; Tang, W.; Yan, R.; Guo, H.; Chen, X. Identification of Hydrolyzable Tannins (Punicalagin, Punicalin and Geraniin) as Novel Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA. Antiviral Research 2016, 134, 97–107. DOI:10.1016/j.antiviral.2016.08.026.
   PubMed Web of Science ®Google Scholar
• Chao, C. Y.; Yin, M. C.; Huang, C. J. Wild Bitter Gourd Extract Up-Regulates mRNA Expression of PPARα, PPARγ and Their Target Genes in C57BL/6J Mice. Journal of Ethnopharmacology 2011, 135(1), 156–161. DOI: 10.1016/j.jep.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, S.; Muhammad, N.; Steele, R.; Peng, G.; Ray, R. B. Immunomodulatory Role of Bitter Melon Extract in Inhibition of Head and Neck Squamous Cell Carcinoma Growth. Oncotarget 2016, 22, 33202–33209.
   Google Scholar
• Martínez-Abundis, E.; Mendez-Del Villar, M.; Perez-Rubio, K. G.; Zuniga, L. Y.; Cortez-Navarrete, M.; Ramírez-Rodriguez, A.; González-Ortiz, M. Novel Nutraceutic Therapies for the Treatment of Metabolic Syndrome. World Journal of Diabetes 2016, 7(7), 142–152. DOI: 10.4239/wjd.v7.i7.142.
   PubMed Web of Science ®Google Scholar
• Huang, Z.; Huang, Q.; Ji, L.; Wang, Y.; Qi, X.; Liu, L.; Liu, Z.; Lu, L. Epigenetic Regulation of Active Chinese Herbal Components for Cancer Prevention and Treatment: A Follow-Up Review. Pharmacological Research 2016, 114, 1–12. DOI:10.1016/j.phrs.2016.09.023.
   PubMed Web of Science ®Google Scholar
• Kavitha, N.; Babu, S. M.; Rao, M. E. Influence of Momordica Charantia on Oxidative Stress-Induced Perturbations in Brain Monoamines and Plasma Corticosterone in Albino Rats. Indian Journal of Pharmacology 2011, 43(4), 424–428. DOI: 10.4103/0253-7613.83114.
   PubMed Web of Science ®Google Scholar
• Tabackman, A. A.; Frankson, R.; Marsan, E. S.; Perry, K.; Cole, K. E. Structure of ‘Linkerless’ Hydroxamic Acid inhibitor-HDAC8 Complex Confirms the Formation of an Isoform-Specific Subpocket. Journal of Structural Biology 2016, 195(3), 373–378. DOI: 10.1016/j.jsb.2016.06.023.
   PubMed Web of Science ®Google Scholar
• Gil, M.I.; Tomás-Barberán, F.A.; Hess-Pierce, B.Kader, A.A. Antioxidant Capacities, Phenolic Compounds, Carotenoids, and Vitamin C Contents Of Nectarine, Peach, and Plum Cultivars from California. Journal Of Agricultural Food Chemistry 2002, 50, 4976–4982. doi:10.1021/jf020136b
   PubMed Web of Science ®Google Scholar
• Rawlings, C. R.; Fremlin, G. A.; Nash, J.; Harding, K. A Rheumatology Perspective on Cutaneous Vasculitis: Assessment and Investigation for the Non-Rheumatologist. International Wound Journal 2016, 13(1), 17–21. DOI: 10.1111/iwj.12437.
   PubMed Web of Science ®Google Scholar
• Faden, A. I.; Loane, D. J. Chronic Neurodegeneration after Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?. Neurotherapeutics 2015, 12(1), 143–150. DOI: 10.1007/s13311-014-0319-5.
   PubMed Web of Science ®Google Scholar
• Kamath, C.C.; Vickers, K.S.; Ehrlich, A.; McGovern, L.; Johnson, J.; Singhal, V.; Paulo, R.; Hettinger, A.; Erwin, P.J.Montori, V.M. Behavioral Interventions to Prevent Childhood Obesity: a Systematic Review and Metaanalyses Of Randomized Trials. The Journal Of Clinical Endocrinology & Metabolism. 2008, 93(12),4606-4615. doi:10.1210/jc.2006-2411
   PubMed Web of Science ®Google Scholar
• Brandao, D. O.; Guimaraes, G. P.; Santos, R. L.; Junior, F. J.; Da Silva, K. M.; De Souza, F. S.; Macedo, R. O. Model Analytical Development for Physical, Chemical, and Biological Characterization of Momordica Charantia Vegetable Drug. Journal of Analytical Methods in Chemicals 2016, 75, 282–297.
   Google Scholar
• Braca, A.; Siciliano, T.; D’Arrigo, M.; Germanò, M. P. Chemical Composition and Antimicrobial Activity of Momordica Charantia Seed Essential Oil. Fitoterapia 2008, 79(2), 123–125. DOI: 10.1016/j.fitote.2007.11.002.
   PubMed Web of Science ®Google Scholar
• Santos, K. K.; Matias, E. F.; Sobral-Souza, C. E.; Tintino, S. R.; Morais-Braga, M. F.; Guedes, G. M.; Santos, F. A. A.; Sousa, A. C.; Rolón, M.; Vega, C.; et al. Trypanocide, Cytotoxic, and Antifungal Activities of Momordica Charantia. Pharmaceutical Biology 2012, 50(2), 162–166. DOI:10.3109/13880209.2011.581672.
   PubMed Web of Science ®Google Scholar
• Zhu, F.; Zhang, P.; Meng, Y. F.; Xu, F.; Zhang, D. W.; Cheng, J.; Lin, H. H.; Xi, D. H. Alpha-Momorcharin, a RIP Produced by Bitter Melon, Enhances Defense Response in Tobacco Plants against Diverse Plant Viruses and Shows Antifungal Activity in Vitro. Planta 2013, 237(1), 77–88. DOI: 10.1007/s00425-012-1746-3.
   PubMed Web of Science ®Google Scholar
• Prabhakar, K.; Kumar, L. S.; Rajendran, S.; Chandrasekaran, M.; Bhaskar, K.; Sajit-Khan, A. K. Antifungal Activity of Plant Extracts against Candida Species from Oral Lesions. Indian Journal of Pharmaceutical Science 2008, 70(6), 801–803. DOI: 10.4103/0250-474X.49128.
   PubMed Web of Science ®Google Scholar
• Chunthorng-Orn, J.; Panthong, S.; Itharat, A. Antimicrobial, Antioxidant Activities and Total Phenolic Content of Thai Medicinal Plants Used to Treat HIV Patients. Journal of the Medical Association of Thailand. 2012, 95(1), 154–158.
   Google Scholar
• Phillips, E. A.; Sexton, D. W.; Steverding, D. Bitter Melon Extract Inhibits Proliferation of Trypanosoma Brucei Bloodstream Forms in Vitro. Experimental Parasitology 2013, 133(3), 353–356. DOI: 10.1016/j.exppara.2012.12.004.
   PubMed Web of Science ®Google Scholar
• Mwambete, K. D. The in Vitro Antimicrobial Activity of Fruit and Leaf Crude Extracts of Momordica Charantia: A Tanzania Medicinal Plant. African Health Science 2009, 9(1), 34–39.
   PubMed Web of Science ®Google Scholar
• Yaldız, G.; Sekeroglu, N.; Kulak, M.; Demirkol, G. Antimicrobial Activity and Agricultural Properties of Bitter Melon (Momordica Charantia L.) Grown in Northern Parts of Turkey: A Case Study for Adaptation. Natural Products Research 2015, 29(6), 543–545. DOI: 10.1080/14786419.2014.949706.
   PubMed Web of Science ®Google Scholar
• Gupta, S.; Raychaudhuri, B.; Banerjee, S.; Das, B.; Mukhopadhaya, S.; Datta, S. C. Momordicatin Purified from Fruits of Momordica Charantia Is Effective to Act as a Potent Antileishmania Agent. Parasitology International 2010, 59(2), 192–197. DOI: 10.1016/j.parint.2010.01.004.
   PubMed Web of Science ®Google Scholar
• Maurya, P.; Sharma, P.; Mohan, L.; Batabyal, L.; Srivastava, C. N. Evaluation of Larvicidal Nature of Fleshy Fruit Wall of Momordica Charantia Linn. (Family: Cucurbitaceae) in the Management of Mosquitoes. Journal of Parasitology Research 2009, 105(6), 1653–1659. DOI: 10.1007/s00436-009-1609-4.
   Web of Science ®Google Scholar
• Olasehinde, G. I.; Ojurongbe, O.; Adeyeba, A. O.; Fagade, O. E.; Valecha, N.; Ayanda, I. O.; Ajayi, A. A.; Egwari, L. O. In Vitro Studies on the Sensitivity Pattern of Plasmodium Falciparum to Anti-Malarial Drugs and Local Herbal Extracts. Malaria Journal 2014, 13, 63. DOI:10.1186/1475-2875-13-63.
   PubMed Web of Science ®Google Scholar
• Gbedema, S. Y.; Bayor, M. T.; Annan, K.; Wright, C. W. Clerodane Diterpenes from Polyalthia Longifolia (Sonn) Thw. Var. Pendula: Potential Antimalarial Agents for Drug Resistant Plasmodium Falciparum Infection. Journal of Ethnopharmacology 2015, 169, 176–182. DOI:10.1016/j.jep.2015.04.014.
   PubMed Web of Science ®Google Scholar
• Chen, J.; Tian, R.; Qiu, M.; Lu, L.; Zheng, Y.; Zhang, Z. Trinorcucurbitane and Cucurbitane Triterpenoids from the Roots of Momordica Charantia. Photochemistry 2008, 69(4), 1043–1048. DOI: 10.1016/j.phytochem.2007.10.020.
   Web of Science ®Google Scholar
• Meng, Y.; Lin, S.; Liu, S.; Fan, X.; Li, G.; Meng, Y. A Novel Method for Simultaneous Production of Two Ribosome-Inactivating Proteins, α-MMC and MAP30, from Momordica Charantia L. PLoS One 2014, 9(7), 101–109. DOI: 10.1371/journal.pone.0101998.
   Web of Science ®Google Scholar
• Kai, H.; Akamatsu, E.; Torii, E.; Kodama, H.; Yukizaki, C.; Sakakibara, Y.; Suiko, M.; Morishita, K.; Kataoka, H.; Matsuno, K. Inhibition of Proliferation by Agricultural Plant Extracts in Seven Human Adult T-Cell Leukaemia (Atl)-Related Cell Lines. Journal of Natural Science 2011, 65(3–4), 651–655.
   Google Scholar
• Laverdure, S.; Polakowski, N.; Hoang, K.; Lemasson, I. Permissive Sense and Antisense Transcription from the 5ʹ and 3ʹ Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1. Journal of Virology 2016, 90(7), 3600–3610. DOI: 10.1128/JVI.02634-15.
   PubMed Web of Science ®Google Scholar
• Kappagoda, S.; Singh, U.; Blackburn, B. G. Antiparasitic Therapy. Mayo Clinic Proceedings 2011, 86, 561–583. DOI:10.4065/mcp.2011.0203.
   PubMed Web of Science ®Google Scholar
• Rajeswari, V. Anthelmintic Activity of Plants: A Review. Research Journal of Photochemistry 2014, 8, 57–63. DOI:10.3923/rjphyto.2014.57.63.
   Google Scholar
• Veerakumari, L. Botanical Anthelmintic. Asian Journal of Science and Technology 2015, 6, 1881–1894.
   Google Scholar
• Hrckova, G.; Velebny, S. Pharmacological Potential of Selected Natural Compounds in the Control of Parasitic Diseases. In Parasitic Helminths of Humans and Animals: Health Impact and Control; Springer: Vienna, 2013; pp 29–99.
   Google Scholar
• Melzig, M. F.; Bader, G.; Loose, R. Investigations of the Mechanism of Membrane Activity of Selected Triterpenoid Saponins. Planta Medicine 2001, 67, 43–48. DOI:10.1055/s-2001-10632.
   PubMed Web of Science ®Google Scholar
• Bauri, R.; Tigga, M.; Kullu, S. A Review on Use of Medicinal Plants to Control Parasites. Indian Journal of Natural Products and Resources 2015, 6, 268–277.
   Web of Science ®Google Scholar
• Wink, M. Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites. Molecules 2012, 17, 12771–12791. DOI:10.3390/molecules171112771.
   PubMed Web of Science ®Google Scholar
• Jain, P.; Singh, S.; Singh, S.; Verma, S.; Kharya, M.; Solanki, S. Anthelmintic Potential of Herbal Drugs. International Journal of Research and Development 2013, 2, 412–417.
   Google Scholar
• Ferrándiz, M. L.; Alcaraz, M. J. Anti-Inflammatory Activity and Inhibition of Arachidonic Acid Metabolism by Flavonoids. Agents Actions 1991, 32, 283–288. DOI:10.1007/BF01980887.
   PubMedGoogle Scholar
• Yoon, Y. A.; Kim, H.; Lim, Y.; Shim, Y. H. Relationships between the Larval Growth Inhibition of Caenorhabditis Elegans by Apigenin Derivatives and Their Structures. Archives of Pharmacal Research 2006, 29, 582–586. DOI:10.1007/BF02969269.
   PubMed Web of Science ®Google Scholar
• Iqbal, Z.; Mufti, K.; Khan, M. Anthelmintic Effects of Condensed Tannins. International Journal of Agriculture Biology 2004, 4, 438–440.
   Google Scholar
• Williams, A.; Fryganas, C.; Ramsay, A.; Mueller-Harvey, I.; Thamsborg, S. Direct Anthelmintic Effects of Condensed Tannins from Diverse Plant Sources against Ascaris Suum. PLoS One 2014, 9, 99738. DOI:10.1371/journal.pone.0097053.
   Web of Science ®Google Scholar
• Ilhan, M.; Bolat, I. E.; Suntar, I.; Kutluay, K.; Ugar Cankal, H.; Keles, D. A.; Kupeli, H.; Akkol, E. Topical Application of Olive Oil Macerate of Momordica Charantia L. Promotes Healing of Excisional and Incisional Wounds in Rat Buccal Mucosa. Archives of Oral Biology 2015, 60(12), 1708–1713. DOI: 10.1016/j.archoralbio.2015.09.006.
   PubMed Web of Science ®Google Scholar
• Hussan, F.; Teoh, S. L.; Muhamad, N.; Mazlan, M.; Latiff, A. A. Momordica Charantia Ointment Accelerates Diabetic Wound Healing and Enhances Transforming Growth factor-β Expression. Journal of Wound Care. 2014, 23(8), 404–407. DOI: 10.12968/jowc.2014.23.8.400.
   Web of Science ®Google Scholar
• Gadang, V.; Gilbert, W.; Hettiararchchy, N.; Horax, R.; Katwa, L.; Devareddy, L. Dietary Bitter Melon Seed Increases Peroxisome Proliferator-Activated receptor-γ Gene Expression in Adipose Tissue, Down-Regulates the Nuclear factor-κB Expression, and Alleviates the Symptoms Associated with Metabolic Syndrome. Journal of Medicinal Food 2011, 14(1–2), 86–93. DOI: 10.1089/jmf.2010.0010.
   PubMed Web of Science ®Google Scholar
• Xu, X.; Shan, B.; Liao, C. H.; Xie, J. H.; Wen, P. W.; Shi, J. Y.Anti-Diabetic Properties of Momordica Charantia L. Polysaccharide in Alloxan-Induced Diabetic Mice. International Journal of Biological Sciences 2015, 81, 538–543.
   Google Scholar
• Singh, R.; Kumar, A.; Singh, M. L.; Maurya, S. K.; Pandey, K. D. Microbial Diversity in the Rhizosphere of Momordica Charantia L. (Bitter Gourd). International journal of current microbiology and applied sciences 2017, 6(2), 67–76. DOI: 10.20546/ijcmas.
   Google Scholar